Sarepta Therapeutics Inc. (SRPT)
NASDAQ: SRPT
· Real-Time Price · USD
21.82
1.52 (7.49%)
At close: Aug 15, 2025, 3:59 PM
21.76
-0.30%
After-hours: Aug 15, 2025, 07:58 PM EDT
Sarepta Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -57.96M | -248.39M | 235.24M | 121.84M | 47.3M | 16.9M | -535.98M | -690.88M | -907.68M | -1.12B | -703.49M | -716.23M | -506.63M | -356.56M | -418.78M | -486.12M | -634.47M | -703.89M |
Depreciation & Amortization | 33.12M | 35.01M | 37.72M | 42.5M | 51.59M | 49.65M | 48.26M | 43.58M | 43.35M | 42.45M | 41.86M | 41.46M | 41.25M | 39.81M | 38.02M | 35.16M | 31.28M | 29.31M |
Stock-Based Compensation | 171.58M | 185.04M | 184.3M | 180.45M | 185.06M | 181.96M | 182.51M | 187.2M | 189.56M | 245.07M | 233.02M | 212.29M | 188.56M | 114.63M | 113.94M | 113.69M | 113.91M | 112.55M |
Other Working Capital | 598.28M | 511.93M | 361.19M | 245.47M | -295.39M | -278.32M | -132.55M | -139.02M | -135.54M | -118.02M | -74.62M | -25.8M | -28.79M | -7.55M | 13.96M | -67.29M | -137.66M | -196.46M |
Other Non-Cash Items | -697.49M | -359.64M | 20.06M | 22.16M | 549.99M | 375.58M | 285.3M | 292.52M | 410.96M | 519.14M | 142.73M | 141.17M | 14.4M | -91.14M | -94M | -93.24M | -35.96M | 69.61M |
Deferred Income Tax | n/a | n/a | n/a | -11.04M | 7.68M | n/a | n/a | 11.04M | -7.68M | n/a | n/a | 1.21M | 9.89M | 13.68M | 15.81M | 18.6M | 13.1M | 11.91M |
Change in Working Capital | 250M | -77.16M | -124.99M | -150.29M | -679.99M | -681.64M | -481.09M | -382.19M | -217.49M | -125.01M | -39.47M | 57.82M | -69.11M | -84.4M | -98.17M | -176.47M | -190.1M | -220.2M |
Operating Cash Flow | -300.75M | -547.15M | -205.79M | -352.49M | -396.5M | -533.67M | -500.99M | -538.73M | -488.99M | -433.57M | -325.35M | -262.28M | -321.64M | -363.98M | -443.17M | -588.38M | -702.24M | -700.7M |
Capital Expenditures | -140.79M | -140.4M | -136.96M | -117.91M | -131.56M | -120.3M | -87.34M | -76.27M | -43.59M | -34.76M | -30.82M | -25.07M | -26.08M | -22.89M | -38.49M | -64.89M | -80.96M | -94.23M |
Cash Acquisitions | n/a | n/a | n/a | 11.24M | n/a | n/a | n/a | -11.24M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -596.97M | -1.17B | -1.1B | -1.51B | -1.77B | -1.84B | -2.05B | -1.9B | -1.63B | -1.58B | -1.94B | -1.51B | -1.14B | -779.77M | -29.99M | -465.87M | -606.82M | -998.12M |
Sales Maturities Of Investments | 1.37B | 1.57B | 2B | 1.57B | 1.74B | 1.9B | 1.87B | 1.79B | 1.71B | 1.37B | 923.22M | 476.72M | 107.15M | 256M | 466M | 807.5M | 998.5M | 1.15B |
Other Investing Acitivies | -258.25M | -81.6M | 171.88M | 160.64M | 182.02M | 353.33M | 102M | 112.04M | 100.15M | -2.04M | -2.43M | -1.6M | -1.58M | 99.6M | 97.89M | 97.36M | 97.18M | -4.5M |
Investing Cash Flow | 376.33M | 245.59M | 755.56M | -72.92M | -154.66M | 40.5M | -165.8M | -91.65M | 138.04M | -248.58M | -1.05B | -1.06B | -1.06B | -447.06M | 495.41M | 374.1M | 407.91M | 52.63M |
Debt Repayment | -3.21M | -3.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -25.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -6.33M | -6.33M | -6.33M | -6.33M |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 76.42M | 115.14M | 124.81M | 77.76M | 79.41M | 45.35M | 125M | 133.81M | 334.83M | 329.31M | 232.51M | 222.47M | 11.95M | 15.13M | 13.04M | 339.26M | 352.14M | 366.19M |
Financial Cash Flow | 51.4M | 115.14M | 124.81M | 77.76M | 79.41M | 45.35M | 125M | 133.81M | 334.83M | 329.31M | 232.51M | 771.01M | 560.48M | 563.67M | 561.57M | 339.26M | 352.14M | 366.19M |
Net Cash Flow | 142.56M | -170.84M | 690.16M | -328.5M | -468.18M | -444.25M | -538.22M | -496.57M | -16.11M | -352.84M | -1.14B | -550.53M | -819.28M | -247.37M | 613.81M | 124.98M | 57.82M | -281.88M |
Free Cash Flow | -441.55M | -687.55M | -342.74M | -470.4M | -528.06M | -653.98M | -588.34M | -615M | -532.58M | -468.32M | -356.17M | -287.35M | -347.72M | -386.87M | -481.66M | -653.27M | -783.19M | -794.93M |